Patent · US Active

Use of substituted 2-aminotetralins for preventive treatment of parkinson's disease

US8283376B2 · kind B2 · utility

2Cited by

33References

12Claims

0Family size

Assignee

UCB Pharma GMBH · DE

Inventors

Dieter Scheller · Brussels, BE
Frank Dressen · Zülpich, DE

Key dates

Filing date	Dec 23, 2004
Grant date	Oct 9, 2012
Priority date	—
Expiry date	Dec 26, 2026

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of substituted 2-aminotetralins of general formula (I)as a medicament for the preventive treatment of Parkinson's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.